Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Price:
10.665
USD
0.42%
Market Cap:
$897.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
CRVS Price Forecast
Based on 8 analysts
Based on 8 analysts
+187% Upside
from
$10.665
today
Corvus Pharmaceuticals Inc (CRVS)’s 12-month stock price forecast through November 2027 has a consensus target of $30.6, implying 187% upside. The forecast is based on price targets from 8 Wall Street analysts.
CRVS Analyst Rating
Based on 7 analysts
Based on 7 analysts
Analysts rate CRVS Strong buy, with 7 of 7 recommending Buy or Strong buy.
Corvus Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRVS's stock price target?
Price Target
30.6
USD
30.6
USD
According to Wall Street analysts, the average 1-year price target for CRVS is 30.6 USD with a low forecast of 27.27 USD and a high forecast of 44.1 USD.
